STOCK TITAN

Celtic Lux (ALVO) boosts Alvotech holding with $38M PIPE and $40M loan

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Celtic Holdings S.C.A. and Celtic Lux Holdings S.a r.l. updated their large shareholder disclosure for Alvotech. They report beneficial ownership of 107,450,988 Ordinary Shares, representing about 27.5% of Alvotech, based on 390,431,480 shares outstanding as of the company’s recent public offering and concurrent private placement.

On June 26, 2026, Celtic Lux bought 10,133,333 Ordinary Shares at $3.75 per share, investing $38,000,000 through a PIPE transaction funded by a $40,000,000 senior secured term loan. All Alvotech shares held by Celtic Lux, including the new PIPE shares, are pledged as collateral. Celtic Lux also entered into a 90‑day lock-up restricting sales and registration activity after the June 16, 2026 prospectus supplement, and received demand registration rights for the PIPE shares.

Positive

  • None.

Negative

  • None.

Insights

Large holder increases stake via leveraged PIPE and pledges all shares.

Celtic Lux now beneficially owns 107,450,988 Alvotech shares, or 27.5% of the company, after purchasing 10,133,333 shares at $3.75 per share in a PIPE financed by a $40,000,000 term loan.

The loan is a senior secured facility maturing 12 months after first use, with no cash interest unless there is an event of default, when a 2% rate applies. All Alvotech shares held by Celtic Lux are pledged as collateral, giving lenders potential foreclosure and voting rights upon default.

Celtic Lux agreed to a 90‑day lock-up after the June 16, 2026 prospectus supplement, limiting near‑term share sales. It also obtained demand registration rights, allowing it to request up to two SEC registrations for resale, including underwritten offerings, which could influence future trading liquidity depending on how these rights are used.

Beneficial ownership 107,450,988 shares Ordinary Shares beneficially owned by Reporting Persons
Ownership percentage 27.5% Percent of Alvotech Ordinary Shares outstanding
Shares outstanding baseline 390,431,480 shares Ordinary Shares outstanding as of public offering and private placement
PIPE shares purchased 10,133,333 shares Ordinary Shares bought by Celtic Lux on June 26, 2026
PIPE price $3.75 per share Purchase price in PIPE Investment
PIPE investment size $38,000,000 Aggregate consideration for PIPE Investment
Loan facility $40,000,000 Senior secured term loan to fund PIPE and costs
Default interest rate 2% per annum Interest on Loan only if an event of default occurs
PIPE Investment financial
"The Ordinary Shares acquired in the PIPE Investment (as defined in Item 4 below) were funded through the proceeds of the Loan"
A pipe investment is a private sale of stock or convertible securities made directly to selected investors by a company that is already publicly traded, allowing the company to raise cash quickly without a full public offering. It matters to investors because it can dilute existing share value and change ownership stakes, but also signals that the company secured financing; like a homeowner taking a quick private loan to cover a repair, it can be a sign of needed funds or investor confidence.
Demand Registration regulatory
"Celtic Lux may, at any time and from time to time, make a written demand for registration ... on any available form of registration statement (a "Demand Registration")"
Demand registration is when a company files the legal paperwork to allow certain existing shareholders to sell their shares publicly at the shareholders’ request. Think of it like the company unlocking a door so holders can sell large blocks of stock; it increases the number of shares available to trade and can affect liquidity and short‑term share price. Investors watch these filings because they signal potential insider selling and change supply dynamics in the market.
lock-up agreement financial
"Celtic Lux entered into a lock-up agreement (the "Lock-Up Agreement") for the benefit of the underwriters of such public offering"
A lock-up agreement is a contract that prevents company insiders and early investors from selling their shares for a fixed period after a stock sale, often after an initial public offering. It matters to investors because it temporarily limits the number of shares that can hit the market, which can keep the share price steadier; when the lock-up ends, a sudden increase in available shares can create extra volatility, revealing insiders’ confidence or lack thereof.
senior secured term loan facility financial
"to obtain a senior secured term loan facility of $40,000,000 (the "Loan")"
A senior secured term loan facility is a type of borrowed money that a company takes out, which is backed by its valuable assets like property or equipment. Because it is secured by these assets and ranks higher in repayment priority, it is considered safer for lenders and typically offers lower interest rates. For investors, it provides a relatively stable and priority claim on the company's assets if it encounters financial difficulties.
Pledged Shares financial
"including the shares purchased in the PIPE Investment (the "Pledged Shares")"
beneficial ownership financial
"The Reporting Persons' aggregate percentage of beneficial ownership is approximately 27.5%."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





L01800108

(CUSIP Number)
Carmen Andre
c/o Celtic Holdings S.C.A., 29, Avenue de la Porte-Neuve
Grand-Duchy of Luxembourg, N4, L-2227
35220880825

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
06/26/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Rows 8, 10, and 11: Through intermediary holding entities, Celtic Lux Holdings S.a r.l. ("Celtic Lux") is a wholly-owned subsidiary of Celtic Holdings S.C.A. ("Celtic Holdings"). Investment and voting decisions at Celtic Holdings are made by a majority vote of its board of directors, subject to certain shareholders having consent rights over material actions and decisions of Celtic Holdings. Therefore, no individual director of Celtic Holdings is the beneficial owner of the securities, except with respect to the shares in which such director holds a pecuniary interest. Note to Row 13: Based on an aggregate of 390,431,480 Ordinary Shares outstanding as of the consummation of the Issuer's public offering and concurrent private placement as reported in the Issuer's Report on 6-K and the exhibit attached thereto, as filed with the Securities and Exchange Commission on June 18, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Rows 8, 10, and 11: Through intermediary holding entities, Celtic Lux Holdings S.a r.l. ("Celtic Lux") is a wholly-owned subsidiary of Celtic Holdings S.C.A. ("Celtic Holdings"). Investment and voting decisions at Celtic Holdings are made by a majority vote of its board of directors, subject to certain shareholders having consent rights over material actions and decisions of Celtic Holdings. Therefore, no individual director of Celtic Holdings is the beneficial owner of the securities, except with respect to the shares in which such director holds a pecuniary interest. Note to Row 13: Based on an aggregate of 390,431,480 Ordinary Shares outstanding as of the consummation of the Issuer's public offering and concurrent private placement as reported in the Issuer's Report on 6-K and the exhibit attached thereto, as filed with the Securities and Exchange Commission on June 18, 2026.


SCHEDULE 13D


Celtic Holdings S.C.A.
Signature:/s/ Carmen Andre
Name/Title:Carmen Andre/Class A Director
Date:06/30/2026
Celtic Lux Holdings S.a r.l.
Signature:/s/ Tomas Ekman
Name/Title:Tomas Ekman/Class A Director
Date:06/30/2026

FAQ

How many Alvotech (ALVO) shares do Celtic Holdings and Celtic Lux currently own?

Celtic Holdings and Celtic Lux report beneficial ownership of 107,450,988 Alvotech Ordinary Shares. This represents approximately 27.5% of Alvotech, based on 390,431,480 shares outstanding as of the company’s public offering and concurrent private placement referenced in the filing.

What PIPE investment in Alvotech (ALVO) did Celtic Lux make in June 2026?

On June 26, 2026, Celtic Lux purchased an aggregate of 10,133,333 Ordinary Shares of Alvotech at $3.75 per share. This PIPE Investment totaled $38,000,000 and was executed under a subscription agreement dated June 16, 2026 between Celtic Lux and the issuer.

How was the Alvotech (ALVO) PIPE investment by Celtic Lux financed?

The PIPE Investment was funded through a $40,000,000 senior secured term loan facility. Celtic Lux entered a Facility Agreement on June 26, 2026 and borrowed $40,000,000, to be used solely to finance the PIPE Investment and related transaction costs, according to the disclosure.

What lock-up restrictions affect Celtic Lux’s Alvotech (ALVO) shares?

Celtic Lux entered a lock-up agreement on June 10, 2026 tied to Alvotech’s underwritten public offering. For 90 days after the June 16, 2026 prospectus supplement date, Celtic Lux agreed not to sell, swap, or exercise registration rights on its Ordinary Shares, subject to customary exceptions.

What registration rights did Celtic Lux receive for its Alvotech (ALVO) PIPE shares?

Under the Subscription Agreement, Celtic Lux obtained demand registration rights for the PIPE shares. It may request registration of all or part of these shares, including underwritten offerings, with the issuer obligated to use reasonable best efforts, but limited to two Demand Registrations in total.

Are Celtic Lux’s Alvotech (ALVO) shares pledged as collateral for its loan?

Yes. The $40,000,000 Loan is secured by a pledge of all Alvotech Ordinary Shares held by Celtic Lux, including the PIPE shares. Before any event of default, Celtic Lux retains voting and dividend rights; after specified defaults, lenders may foreclose and exercise voting rights over the pledged shares.